FDA Releases Guidance on Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for In Vitro Diagnostic Devices

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for manufacturers of in vitro diagnostic devices to determine whether their laboratory tests can be performed by laboratories with a certificate of waiver under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)